Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
52 studies found for:    NP001
Show Display Options
Rank Status Study
1 Completed Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: NP001;   Drug: Placebo
2 Completed A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: NP001;   Drug: Placebo
3 Completed Comparison of Three Tourniquet Application Methods in Primary Total Knee Arthroplasty Surgery
Condition: Knee Osteoarthritis
Intervention: Procedure: Total knee arthroplasty performed under tourniquet
4 Terminated
Has Results
A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)
Condition: Osteoporosis
Interventions: Drug: MK-5442;   Drug: Placebo;   Dietary Supplement: Vitamin D3;   Dietary Supplement: Calcium carbonate
5 Completed A Study to Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults
Condition: Influenza
Intervention: Biological: MVA-NP+M1
6 Active, not recruiting Safety and Immunogenicity Study of SeV-G(NP) HIV Vaccine Administered Intranasally and Ad35-GRIN HIV Vaccine Given Intramuscularly in Prime-Boost Regimens in HIV-Uninfected Volunteers
Condition: HIV Infections
Interventions: Biological: SeV-G(NP) (0.2mL, 2x10^7 CIU);   Biological: SeV-G(NP) (0.2mL, 2x10^8 CIU);   Biological: Ad35-GRIN (0.5mL)
7 Active, not recruiting Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: intrathecal administration of autologous MSC-NP
8 Completed Safety and Pharmacodynamic Study of CD-NP
Condition: Heart Failure, Congestive
Intervention: Drug: CD-NP
9 Not yet recruiting Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Intervention: Drug: KRN23
10 Completed Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy
Condition: Parkinson's Disease
Interventions: Drug: nicotine;   Other: placebo comparator
11 Completed Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)
Condition: Non-small Cell Lung Cancer
Intervention: Drug: recombinant human endostatin
12 Recruiting Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Conditions: Epstein-Barr Virus Infection;   Stage II Lymphoepithelioma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Other: clinical observation;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
13 Completed Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum
Condition: Symptoms of Inhalational Anthrax
Intervention: Biological: NP-015
14 Completed Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses
Condition: Healthy
Intervention: Biological: Botulinum Antitoxin Heptavalent (A B C D E F G) - (EQUINE)
15 Completed Neuropathic Pain Caused by Radiation Therapy
Condition: Neuropathic Pain Secondary to Radiation Therapy
Intervention: Drug: topical amitriptyline 2%, ketamine 1%, and lidocaine 5% in pluronic lecitine organogel(AKL in PLO gel)
16 Recruiting Everolimus for Cancer With TSC1 or TSC2 Mutation
Conditions: TSC1;   TSC2;   Tuberous Sclerosis Complex
Intervention: Drug: Everolimus
17 Recruiting Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations
Condition: Non-small Cell Lung Cancer Stage IIIA
Interventions: Drug: Erlotinib;   Drug: vinorelbine/cisplatin
18 Completed
Has Results
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Condition: Breast Cancer
Interventions: Drug: Everolimus;   Drug: Fulvestrant
19 Completed
Has Results
PTH & Ibandronate Combination Study (PICS)
Condition: Osteoporosis
Interventions: Drug: PTH(1-84);   Drug: Ibandronate;   Other: Placebo injection;   Other: Placebo pills
20 Completed Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
Conditions: Minimal Hepatic Encephalopathy;   Hepatic Encephalopathy
Intervention: Drug: Lactulose

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years